Amikacin is a lot of generally acclimated
for alleviative severe, hospital-acquired infections with multidrug-resistant
Gram-negative bacilli such as Pseudomonas aeruginosa, Acinetobacter, and
Enterobacter. Serratia marcescens and Providencia stuartii are aswell included
in the spectrum. Amikacin can aswell be acclimated to amusement non-tubercular
mycobacterial infections and tuberculosis (if acquired by acute strains) if
first-line drugs abort to ascendancy the infection.
Amikacin may be accumulated with a
beta-lactam antibacterial for empiric analysis for humans with neutropenia and
fever.
Liposomal amikacin for assimilation is
currently in backward date analytic trials for the analysis of respiratory
diseases, such as cystic fibrosis, Pseudomonas aeruginosa, non-tubercular
mycobacterial infections and bronchiectasis.
No comments:
Post a Comment